0000885590-15-000026.txt : 20150421
0000885590-15-000026.hdr.sgml : 20150421
20150421174655
ACCESSION NUMBER: 0000885590-15-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150417
FILED AS OF DATE: 20150421
DATE AS OF CHANGE: 20150421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornwasser Laizer
CENTRAL INDEX KEY: 0001387813
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 15783992
MAIL ADDRESS:
STREET 1: 100 PARSONS POND DRIVE
CITY: FRANKLIN LAKES
STATE: NJ
ZIP: 07417
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-04-17
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001387813
Kornwasser Laizer
2150 ST. ELZEAR BLVD. WEST
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
0
1
0
0
EVP, Company Group Chairman
Common Stock, no par value
2015-04-17
4
M
0
45000
0
A
123377
D
Common Stock, no par value
2015-04-17
4
F
0
23337
0
D
100040
D
Restricted Share Units
2015-04-17
4
M
0
45000
0
D
Common Stock
45000
0
D
Each performance-based Restricted Share Unit ("RSU") represents a contingent right to receive between zero and three common shares, no par value ("Common Shares"), of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (2).
These RSUs were initially eligible to vest based on total shareholder return (TSR) between a price of $63.86 starting on February 1, 2013 and the average stock price for the 20 trading days starting on each measurement dates: 25% on November 1, 2015, 50% on February 1, 2016 and 25% on May 1, 2016, contingent on TSR performance between 10% and 30% into between one and three Common Shares of common stock, respectively, with early vesting possible at higher TSR levels. These performance-based RSUs have now vested in full.
This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based RSUs.
by: Nicholas Zanoni for Laizer Kornwasser
2015-04-17